Hunan Jiudian Pharmaceutical (SZ:300705) Zhong Guo Jin Rong Xin Xi Wang·2026-01-04 08:37Core Insights - The innovative small molecule analgesic drug YJ2301 developed by Professor Li Fei's team at Nanjing Medical University has successfully transitioned from laboratory to market with a total transaction value of nearly 400 million yuan through a partnership with Jiutian Pharmaceutical [1] - The establishment of the first national university regional technology transfer center in Jiangsu aims to facilitate the commercialization of academic research, having already connected over 50 domestic and international universities and generated a total intended transaction value exceeding 800 million yuan [1][2] Value Discovery - The BioMatch initiative launched in February 2025 aims to actively promote high-potential projects like YJ2301 by facilitating connections between universities and enterprises, moving away from passive approaches to technology transfer [2][4] - The center's proactive model of "active exploration + precise matching" has fostered an innovative atmosphere where universities are encouraged to transfer technologies and companies are willing to engage [2] Value Cultivation - The center provides technical guidance and financial support to help early-stage projects navigate challenges such as target validation and safety research, which are critical for moving from laboratory to industry [3][6] - For the YJ2301 project, the center's concept validation team conducted comprehensive evaluations and provided tailored plans to facilitate technology transfer [3] Value Protection - The center has introduced a "pay after use" model to alleviate concerns regarding intellectual property risks for both universities and enterprises, allowing companies to test technologies without significant upfront investments [7] - This model has led to the collection of over 1,000 patent results from more than 20 universities, with agreed "post-payment" amounts exceeding 100 million yuan, enhancing opportunities for early-stage projects to reach the market [7] Value Realization - The center acts as an intermediary to bridge the gap between academic research and market needs, providing professional support in negotiations and contract management to ensure successful collaborations [8] - The comprehensive service model established by the center encompasses the entire process from original research to large-scale production, significantly enhancing the commercialization of academic innovations in the biopharmaceutical industry [8]